# clm_61C96CE7DB96

subject: Vertex Pharmaceuticals (/record/vertex-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 172,878,000 United States dollar  
valid_from: 2018-06-30  
valid_to: 2018-09-30  
published: 2018-07-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_D6C88602928F  
last_updated: 2026-11-08  
cite: AsOf. "Vertex Pharmaceuticals quarterly operating income: 172,878,000 United States dollar", as of 2018-06-30 (until 2018-09-30). Claim clm_61C96CE7DB96, https://asof.is/claim/clm_61C96CE7DB96, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532018000022/0000875320-18-000022-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-07-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/875320/000087532018000022/0000875320-18-000022-index.htm (primary, SEC EDGAR 10-Q Q2 FY2018, published 2018-07-26)

## Supersedes

- [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_operating_income | 128,901,000 United States dollar | valid 2018-03-31 to 2018-06-30 | conf 0.95 | superseded | superseded_by [clm_61C96CE7DB96](/claim/clm_61C96CE7DB96.md) | [clm_A620E2C8FB71](/claim/clm_A620E2C8FB71.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.